GeneNews Ltd (TSE:GEN – Get Free Report)’s stock price shot up 7.1% during mid-day trading on Tuesday . The company traded as high as C$0.15 and last traded at C$0.15. 473,147 shares changed hands during mid-day trading, a decline of 68% from the average session volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Trading Up 7.1 %
The business has a 50 day moving average of C$0.15. The stock has a market capitalization of C$25.49 million and a price-to-earnings ratio of -2.21.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Further Reading
- Five stocks we like better than GeneNews
- ETF Screener: Uses and Step-by-Step Guide
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- How to Use the MarketBeat Stock Screener
- Netflix Is On Track To Hit $1,000 By Christmas
- What Are Dividend Achievers? An Introduction
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.
